The Luxembourg Anti-Doping Agency (ALAD) has taken stock of its controls for the year 2017.

During the past year, the ALAD control officers carried out 187 urine tests, to which 8 controls carried out abroad on Luxemburg athletes at the request of ALAD were added. In addition, two controls resulted in a no-show, the athletes not being in the place indicated by them in the ADAMS location system. 144 controls were held at competitions, including 67 unexpectedly.

Under the umbrella of the Cycling Antidoping Foundation (CADF), 30 ALAD control officers actively participated in controls at the World Cyclocross Championships in January 2017. ALAD staff also conducted the anti-doping tests in and out of competition at the European TT Championships in September 2017.

For 33 controls the management of the results came back according to the international regulation governed by the world anti-doping code to the international federation since the competition was on the calendar of international federations. 190 analyses were negative, whilst five analyses (belonging to four athletes) revealed the presence of prohibited substances.

On 10 February 2017, at the Vectis Indoor meeting in La Coque, the sample of the Greek athlete Panagiotis Andreadis revealed the presence of 5-methylhexan-2-amine, a substance listed in section S.6 of the list of prohibited substance. The Greek sports authorities have suspended the athlete for four years.

At the LaLux Ladies Cup Final Cup: Amicale Steesel-Basket Esch on 11 March 2017, the analysis of the urine sample of basketball player Alexandra Williams resulted in a positive result due to the presence of triamcinolone. The CDD has sanctioned a two-year suspension beginning on July 13, 2017.

At the F91 Diddeleng-CS Fola Esch championship match on 14 May 2017, football player Emmanuel Françoise's urine sample test resulted in a positive result due to the presence of Terbutaline. ALAD appealed the decision of the Disciplinary Council against doping which had adopted as a sanction a simple reprimand. The appeal was declared inadmissible thereafter.

The two urine analyses of Matija Kvasina, winner of the South Arrow 2017, revealed the presence of Molidustat. The file has been sent to the UCI for results management and the cyclist has been suspended for four years.